An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer.
Antineoplastic Combined Chemotherapy Protocols
Cell Line, Tumor
Drug Screening Assays, Antitumor
Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info